Monday October 28 11:14 AM EDT
The board of directors of OmniGene Diagnostics Inc. approve a four to one stock split
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 28, 1996--The board of directors of OmniGene Diagnostics Inc. (OTC BB:OMGD) has approved a four to one
stock split to take place on Nov. 15, 1996.
Stockholders of record on that date will be entitled to the split.
OmniGene Diagnostics Inc. has a patented, state of the art DNA probe based test for the detection of periodontal disease. One hundred million people presently suffer
from periodontitis and 32 million are currently being treated for advanced cases of periodontitis. The American Dental Association has targeted the treatment of
periodontitis as its number one goal. The company's spiraling growth is accredited to the growing demand in dentistry for diagnostic testing for early detection of
periodontal disease, the major cause of tooth loss. Early detection and painless, non surgical therapy are increasing in popularity for both dentist and patient.
OmniGene's President, Dominic A. Scacci also announced at the meeting, plans to buy 20 percent, with an option to buy the balance, a company that markets dental
implant practices. This company would assist OmniGene's marketing efforts to educate and promote anti-microbial/antibiotic therapy direct to the public.
"We are on the move and looking to take an aggressive position in the growing dental industry," stated the company's president.
The company also plans to step up its international business expansion by adding more sales offices and laboratories in each hemisphere. "We have been encouraged by
the growth of our Japan, Latin America, and our licensee in Western Europe. We are looking forward to increasing our international sales base," Scacci added.
The company estimates sales at $500,000 in 1996 and project sales to exceed $2 million in 1997.
For more information on OmniGene Diagnostics Inc. and its DNA probe testing please contact the company at 800/391-8101.
CONTACT: OmniGene Diagnostics Inc., Cambridge
Deryl Seemayer, Marketing & Sales Director
561/833-1001 |
